July 2021: The US Food and Medication Administration (FDA) has expanded the indications for pembrolizumab (Keytruda), an immunotherapy drug, to encompass any cancer with a high mutational burden (TMB-H). The new authorization is f..
The research team of Shenzhen Hospital collected 37 samples of bladder cancer patients, performed whole exon sequencing and gene editing techniques, and discovered the culprit of bladder cancer recurrence-"MLL gene".On the 7th, th..
ເດືອນກໍລະກົດ 2021: ກວດເບິ່ງຢາຫຼ້າສຸດໃນການປິ່ນປົວມະເຮັງ. ທຸກໆປີ, ຫຼັງຈາກການກວດສອບການທົດລອງແລະປັດໃຈສໍາຄັນອື່ນໆ, USFDA ອະນຸມັດຢາ, ແລະດັ່ງນັ້ນ, ຄົນເຈັບທີ່ເປັນມະເຮັງໃນປັດຈຸບັນສາມາດເຊື່ອວ່າການປິ່ນປົວແມ່ນຢູ່ໃກ້ໆ. ..